Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


16.07.2018

1 Cardiovasc Res
4 Circ Heart Fail
1 Circ Res
1 Circulation
3 Eur Heart J
2 Eur J Heart Fail
3 Int J Cardiol
1 J Card Fail
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cardiovasc Res

  1. DOBREV D, Fender AC, Wehrens XHT
    Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
    Cardiovasc Res. 2018 Jul 3. pii: 5048462. doi: 10.1093.
    PubMed     Text format    


    Circ Heart Fail

  2. NIJST P, Olinevich M, Hilkens P, Martens P, et al
    Dermal Interstitial Alterations in Patients With Heart Failure and Reduced Ejection Fraction: A Potential Contributor to Fluid Accumulation?
    Circ Heart Fail. 2018;11:e004763.
    PubMed     Text format     Abstract available

  3. GARDNER RS, Singh JP, Stancak B, Nair DG, et al
    HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study.
    Circ Heart Fail. 2018;11:e004669.
    PubMed     Text format     Abstract available

  4. FERREIRA JP, Duarte K, McMurray JJV, Pitt B, et al
    Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.
    Circ Heart Fail. 2018;11:e004926.
    PubMed     Text format     Abstract available

  5. SOLOMON SD, Rizkala AR, Lefkowitz MP, Shi VC, et al
    Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Circ Heart Fail. 2018;11:e004962.
    PubMed     Text format     Abstract available


    Circ Res

  6. GYONGYOSI M, Haller PM, Blake DJ, Martin Rendon E, et al
    Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction.
    Circ Res. 2018;123:301-308.
    PubMed     Text format     Abstract available


    Circulation

  7. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Text format     Abstract available


    Eur Heart J

  8. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. SCHMIEDER RE, Wagner F, Mayr M, Delles C, et al
    The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Eur Heart J. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. VAN EMPEL V, Brunner-La Rocca HP
    Helping to understand heart failure with preserved ejection fraction.
    Eur Heart J. 2018 Jul 9. pii: 5050878. doi: 10.1093.
    PubMed     Text format    


    Eur J Heart Fail

  11. DOEHNER W, Celutkiene J, Haeusler KG
    Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Reply.
    Eur J Heart Fail. 2018 Jul 13. doi: 10.1002/ejhf.1281.
    PubMed     Text format    

  12. CARBONE S, Elagizi A, Lavie CJ
    Obesity and mortality risk in heart failure: when adipose tissue distribution matters.
    Eur J Heart Fail. 2018 Jul 12. doi: 10.1002/ejhf.1279.
    PubMed     Text format    


    Int J Cardiol

  13. KHEIRI B, Osman M, Abdalla A, Haykal T, et al
    Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)32169.
    PubMed     Text format     Abstract available

  14. ZHANG J, Pellicori P, Pan D, Dierckx R, et al
    Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure.
    Int J Cardiol. 2018 Jun 25. pii: S0167-5273(17)37429.
    PubMed     Text format     Abstract available

  15. PEREGO GB
    Why is PAP guided therapy effective?
    Int J Cardiol. 2018;259:137.
    PubMed     Text format    


    J Card Fail

  16. GUAZZI M
    Exercise VE/VCO2 Slope: an Endurance Marker of Prognosis in Patients with HFpEF and Pulmonary Hypertension, at Least!
    J Card Fail. 2017 Sep 11. pii: S1071-9164(17)31168.
    PubMed     Text format    


    PLoS One

  17. DI CARLO A, Lamassa M, Franceschini M, Bovis F, et al
    Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study.
    PLoS One. 2018;13:e0194786.
    PubMed     Text format     Abstract available

  18. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: